Helvetia Baloise stock reports stronger H1 earnings after merger

Published on 10/04/2026 at 16:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Helvetia Baloise stock stood at CHF 205 on October 2, 2026 as H1 underlying earnings reached CHF 631.6 million. Eight analysts set a CHF 233.36 average target.

Trading-Floor der Schweizer Börse mit Bildschirmen und SMI-Aktienindex-Charts — Helvetia Holding AG CH0466642201 wird editorial am Trading-Floor der Schweizer Börse mit SMI-Charts gezeigt, Illustration mit AI erstellt.

Helvetia Baloise (ISIN CH0466642201) stock was last at CHF 205 on October 2, 2026 at 5:30 p.m. CEST, up 0.20 percent on the SIX Swiss Exchange. The insurer's first combined half-year report showed CHF 631.6 million in underlying earnings and a 92.0 percent combined ratio, according to FT.com on September 17, 2026.

H1 earnings show the merger effect

Underlying earnings for the first half of 2026 stood at CHF 631.6 million, compared with CHF 271.8 million in the first half of 2025. The comparison is structurally affected by the merger because the 2025 income statement reflects Helvetia alone, while the 2026 figures cover the combined group, the company announcement said.

Insurance revenue reached CHF 8.17 billion, up from CHF 4.62 billion in the prior-year period. The 92.0 percent combined ratio also improved from 93.3 percent, showing that the enlarged non-life operation maintained underwriting discipline, according to Investing.com on September 17, 2026.

Profit quality carries a clear counterweight

Group IFRS net income was CHF 84.6 million in the first half, down from CHF 320.1 million a year earlier. Merger-related amortization of CHF 671.7 million weighed on the IFRS result, although the company said the charge did not affect dividend capacity.

The operating picture is therefore stronger than the statutory earnings line alone suggests. Helvetia Baloise also reported a 4.1 percent new business margin in life insurance and CHF 13.0 billion of total equity as of June 30, 2026, while integration execution remains central to the investment case.

Analysts see room above CHF 205

MarketScreener's consensus for Helvetia Baloise is Outperform, based on eight analysts, with an average target of CHF 233.36. That target lies 13.8 percent above the CHF 205 reference price, a spread that places the market's valuation debate on future integration benefits rather than on the first half's statutory net income, according to MarketScreener.

Stock stays below the yearly high

Helvetia Baloise stock was last at CHF 205 on October 2, 2026, with a 52-week range of CHF 183.40 to CHF 226.60. Its market capitalization was CHF 20.3 billion and volume was 140,393 shares, leaving the stock 9.54 percent below its 52-week high.